U.S. Speech Therapy Market, By Age Group (Children and Adults), By Indication (Speech Disorders, Language Disorders, Apraxia, Autism Spectrum Disorder (ASD), and Others), By End User (Hospitals, Clinics, Rehabilitation Centers, and Others)

Published In : Feb 2025

Code : CMI4797

Pages :150

Formats :

Excel and PDF

Industry : Medical Devices

U.S. Speech Therapy Market Size and Trends

The U.S. Speech Therapy Market is estimated to be valued at USD 5.29 Bn in 2025 and is expected to reach USD 9.08 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.0% from 2025 to 2032.

U.S. Speech Therapy Market Key Factors

To learn more about this report, Request sample copy

The rising prevalence of communicative and speech disorders among individuals has been driving the market growth. Conditions like developmental delays, cleft lip or palate, swallowing disorders etc. have been on the rise. Moreover, increasing incidence of neurological conditions and accidents resulting in speech impairments have also augmented the need for speech therapy. Growing geriatric population who are more prone to conditions like dementia and Parkinson's disease further leading to difficulties in communication is also fueling the demand for speech therapists. Various technological advancements in speech therapy solutions aiming to provide more effective and convenient treatments are further expected to drive the market during the forecast period.

Rising Incidence of Communication Disorders

The incidence of communication disorders has been steadily increasing over the past few decades. Various factors such as increased life expectancy, growing elderly population, rising air and noise pollution levels, and changed lifestyle habits have all contributed to this rise. Communication disorders can affect people of all ages but are more commonly observed in toddlers, school-going children, and the elderly. Some of the most prevalent communication disorders include speech sound disorders, language disorders, voice disorders, fluency disorders, and hearing loss. For instance, in June 2023, it was observed that 90% of individuals with Parkinson's disease encounter hypokinetic dysarthria, a multifaceted speech disorder. The increasing prevalence of such language impairments coupled with favorable reimbursement schemes for speech-language pathology services in the U.S. is driving the demand for these therapies and is anticipated to propel the market expansion.